Screener
Insmed INSM Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Insmed’s reported figures.
Based on trailing twelve months.
The source filing: Insmed’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104506-26-000032
FAQ
- What is Insmed's return on equity?
- Insmed (INSM) reported return on equity of -294.5% in Q1 2026.
- What is the long-term trend for Insmed's return on equity?
- Over 3 years (2020 to 2025), Insmed's return on equity has grown at a 31.6% compound annual growth rate (CAGR), from -109.4% to -249.3%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Insmed's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude